TPG GP A’s Allogene Therapeutics ALLO Stock Holding History

TPG GP A’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.7M	Hold	18,716,306	–	–	1.24%	15
2025 Q4	$25.6M	Hold	18,716,306	–	–	0.95%	8
2025 Q3	$23.2M	Hold	18,716,306	–	–	1.26%	7
2025 Q2	$21.1M	Hold	18,716,306	–	–	1.13%	8
2025 Q1	$27.3M	Hold	18,716,306	–	–	0.55%	27
2024 Q4	$39.9M	Hold	18,716,306	–	–	0.64%	29
2024 Q3	$52.4M	Hold	18,716,306	–	–	0.89%	23
2024 Q2	$43.6M	Hold	18,716,306	–	–	0.68%	27
2024 Q1	$83.7M	Hold	18,716,306	–	–	1.6%	18
2023 Q4	$60.1M	Hold	18,716,306	–	–	0.97%	26
2023 Q3	$59.3M	Hold	18,716,306	–	–	1.02%	23
2023 Q2	$93M	Hold	18,716,306	–	–	1.37%	19
2023 Q1	$92.5M	Hold	18,716,306	–	–	1.51%	19
2022 Q4	$118M	Hold	18,716,306	–	–	2.31%	16
2022 Q3	$202M	Hold	18,716,306	–	–	3.31%	12
2022 Q2	$213M	Hold	18,716,306	–	–	3.3%	11
2022 Q1	$171M	Hold	18,716,306	–	–	2.11%	14
2021 Q4	$279M	Buy	+18,716,306	New	+$330M	2.79%	10

Other funds holding ALLO

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return